• Morgan Stanley Expansion Capital led a $33 million growth financing in Subtle Medical.
• Shinhan Venture Investment joined the round, with Fusion Fund, EnvisionX, BRV, Samsung Ventures also participating.
• Transaction lifted Subtle Medical’s total capital raised to $86 million.
• Proceeds earmarked for product development, US commercialization, international expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Morgan Stanley published the original content used to generate this news brief via Business Wire (Ref. ID: 20260601886403) on June 02, 2026, and is solely responsible for the information contained therein.